Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
41
TSUSF Quote, Financials, Valuation and Earnings
Last price:
$17.25
Seasonality move
:
14.59%
Day range:
$17.25 - $17.25
52-week range:
$11.00 - $55.00
Dividend yield:
7.28%
P/E ratio:
5.77x
P/S ratio:
0.34x
P/B ratio:
2.08x
Volume:
--
Avg. volume:
--
1-year change:
56.82%
Market cap:
$4.2B
Revenue:
$7B
EPS (TTM):
$2.99
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TSUSF
TSURUHA Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
HLOSF
Healios KK
|
-- | -- | -- | -- | -- |
|
PPTDF
PeptiDream Inc.
|
-- | -- | -- | -- | -- |
|
SOLTF
Nxera Pharma Co., Ltd.
|
-- | -- | -- | -- | -- |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$7.8B | -- | 2.78% | -- | $17.76 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TSUSF
TSURUHA Holdings, Inc.
|
$17.25 | -- | $4.2B | 5.77x | $0.91 | 7.28% | 0.34x |
|
HLOSF
Healios KK
|
$2.50 | -- | $288.5M | -- | $0.00 | 0% | 392.54x |
|
PPTDF
PeptiDream Inc.
|
$10.95 | -- | $1.4B | 13.79x | $0.00 | 0% | 11.79x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$5.00 | -- | $452.5M | -- | $0.00 | 0% | 2.34x |
|
STMM
Stemcell Holdings, Inc.
|
$0.06 | -- | $60M | -- | $0.00 | 0% | 0.17x |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$14.18 | $17.76 | $44.8B | 179.95x | $0.32 | 4.66% | 1.53x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TSUSF
TSURUHA Holdings, Inc.
|
17.3% | 1.966 | 3.12% | 0.70x |
|
HLOSF
Healios KK
|
47.23% | -1.205 | 3.71% | 1.23x |
|
PPTDF
PeptiDream Inc.
|
25.86% | 0.045 | 8.66% | 4.05x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
49.02% | 1.721 | 73.82% | 2.21x |
|
STMM
Stemcell Holdings, Inc.
|
-- | 0.000 | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
39.45% | -0.563 | 68.02% | 0.64x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TSUSF
TSURUHA Holdings, Inc.
|
$589.9M | $109.1M | 8.44% | 9.9% | 5.6% | -- |
|
HLOSF
Healios KK
|
-$637.4K | -$5.2M | -86.08% | -194.37% | -4022.21% | -$5.3M |
|
PPTDF
PeptiDream Inc.
|
$11.3M | -$9.7M | -7.71% | -10.42% | -33.1% | -$12.5M |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$27.7M | -$23.7M | -4.62% | -9.2% | -51.66% | -$20.9M |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$3.6B | $763.2M | 0.33% | 0.55% | 10.11% | $2B |
TSURUHA Holdings, Inc. vs. Competitors
-
Which has Higher Returns TSUSF or HLOSF?
Healios KK has a net margin of 3.51% compared to TSURUHA Holdings, Inc.'s net margin of -9751.87%. TSURUHA Holdings, Inc.'s return on equity of 9.9% beat Healios KK's return on equity of -194.37%.
Company Gross Margin Earnings Per Share Invested Capital TSUSFTSURUHA Holdings, Inc.30.28% $0.26 $2.6B HLOSFHealios KK-494.88% $0.03 $37.8M -
What do Analysts Say About TSUSF or HLOSF?
TSURUHA Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Healios KK has an analysts' consensus of -- which suggests that it could fall by --. Given that TSURUHA Holdings, Inc. has higher upside potential than Healios KK, analysts believe TSURUHA Holdings, Inc. is more attractive than Healios KK.
Company Buy Ratings Hold Ratings Sell Ratings TSUSFTSURUHA Holdings, Inc.0 0 0 HLOSFHealios KK0 0 0 -
Is TSUSF or HLOSF More Risky?
TSURUHA Holdings, Inc. has a beta of 0.413, which suggesting that the stock is 58.676% less volatile than S&P 500. In comparison Healios KK has a beta of 0.210, suggesting its less volatile than the S&P 500 by 78.954%.
-
Which is a Better Dividend Stock TSUSF or HLOSF?
TSURUHA Holdings, Inc. has a quarterly dividend of $0.91 per share corresponding to a yield of 7.28%. Healios KK offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TSURUHA Holdings, Inc. pays 59.57% of its earnings as a dividend. Healios KK pays out -- of its earnings as a dividend. TSURUHA Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TSUSF or HLOSF?
TSURUHA Holdings, Inc. quarterly revenues are $1.9B, which are larger than Healios KK quarterly revenues of $128.8K. TSURUHA Holdings, Inc.'s net income of $68.4M is higher than Healios KK's net income of $3.8M. Notably, TSURUHA Holdings, Inc.'s price-to-earnings ratio is 5.77x while Healios KK's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TSURUHA Holdings, Inc. is 0.34x versus 392.54x for Healios KK. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TSUSFTSURUHA Holdings, Inc.0.34x 5.77x $1.9B $68.4M HLOSFHealios KK392.54x -- $128.8K $3.8M
-
Which has Higher Returns TSUSF or PPTDF?
PeptiDream Inc. has a net margin of 3.51% compared to TSURUHA Holdings, Inc.'s net margin of -25.38%. TSURUHA Holdings, Inc.'s return on equity of 9.9% beat PeptiDream Inc.'s return on equity of -10.42%.
Company Gross Margin Earnings Per Share Invested Capital TSUSFTSURUHA Holdings, Inc.30.28% $0.26 $2.6B PPTDFPeptiDream Inc.38.71% -$0.06 $480.4M -
What do Analysts Say About TSUSF or PPTDF?
TSURUHA Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand PeptiDream Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that TSURUHA Holdings, Inc. has higher upside potential than PeptiDream Inc., analysts believe TSURUHA Holdings, Inc. is more attractive than PeptiDream Inc..
Company Buy Ratings Hold Ratings Sell Ratings TSUSFTSURUHA Holdings, Inc.0 0 0 PPTDFPeptiDream Inc.0 0 0 -
Is TSUSF or PPTDF More Risky?
TSURUHA Holdings, Inc. has a beta of 0.413, which suggesting that the stock is 58.676% less volatile than S&P 500. In comparison PeptiDream Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.146%.
-
Which is a Better Dividend Stock TSUSF or PPTDF?
TSURUHA Holdings, Inc. has a quarterly dividend of $0.91 per share corresponding to a yield of 7.28%. PeptiDream Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TSURUHA Holdings, Inc. pays 59.57% of its earnings as a dividend. PeptiDream Inc. pays out -- of its earnings as a dividend. TSURUHA Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TSUSF or PPTDF?
TSURUHA Holdings, Inc. quarterly revenues are $1.9B, which are larger than PeptiDream Inc. quarterly revenues of $29.3M. TSURUHA Holdings, Inc.'s net income of $68.4M is higher than PeptiDream Inc.'s net income of -$7.4M. Notably, TSURUHA Holdings, Inc.'s price-to-earnings ratio is 5.77x while PeptiDream Inc.'s PE ratio is 13.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TSURUHA Holdings, Inc. is 0.34x versus 11.79x for PeptiDream Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TSUSFTSURUHA Holdings, Inc.0.34x 5.77x $1.9B $68.4M PPTDFPeptiDream Inc.11.79x 13.79x $29.3M -$7.4M
-
Which has Higher Returns TSUSF or SOLTF?
Nxera Pharma Co., Ltd. has a net margin of 3.51% compared to TSURUHA Holdings, Inc.'s net margin of -24.76%. TSURUHA Holdings, Inc.'s return on equity of 9.9% beat Nxera Pharma Co., Ltd.'s return on equity of -9.2%.
Company Gross Margin Earnings Per Share Invested Capital TSUSFTSURUHA Holdings, Inc.30.28% $0.26 $2.6B SOLTFNxera Pharma Co., Ltd.60.42% -$0.13 $872.1M -
What do Analysts Say About TSUSF or SOLTF?
TSURUHA Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Nxera Pharma Co., Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that TSURUHA Holdings, Inc. has higher upside potential than Nxera Pharma Co., Ltd., analysts believe TSURUHA Holdings, Inc. is more attractive than Nxera Pharma Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings TSUSFTSURUHA Holdings, Inc.0 0 0 SOLTFNxera Pharma Co., Ltd.0 0 0 -
Is TSUSF or SOLTF More Risky?
TSURUHA Holdings, Inc. has a beta of 0.413, which suggesting that the stock is 58.676% less volatile than S&P 500. In comparison Nxera Pharma Co., Ltd. has a beta of 0.029, suggesting its less volatile than the S&P 500 by 97.149%.
-
Which is a Better Dividend Stock TSUSF or SOLTF?
TSURUHA Holdings, Inc. has a quarterly dividend of $0.91 per share corresponding to a yield of 7.28%. Nxera Pharma Co., Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TSURUHA Holdings, Inc. pays 59.57% of its earnings as a dividend. Nxera Pharma Co., Ltd. pays out -- of its earnings as a dividend. TSURUHA Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TSUSF or SOLTF?
TSURUHA Holdings, Inc. quarterly revenues are $1.9B, which are larger than Nxera Pharma Co., Ltd. quarterly revenues of $45.8M. TSURUHA Holdings, Inc.'s net income of $68.4M is higher than Nxera Pharma Co., Ltd.'s net income of -$11.3M. Notably, TSURUHA Holdings, Inc.'s price-to-earnings ratio is 5.77x while Nxera Pharma Co., Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TSURUHA Holdings, Inc. is 0.34x versus 2.34x for Nxera Pharma Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TSUSFTSURUHA Holdings, Inc.0.34x 5.77x $1.9B $68.4M SOLTFNxera Pharma Co., Ltd.2.34x -- $45.8M -$11.3M
-
Which has Higher Returns TSUSF or STMM?
Stemcell Holdings, Inc. has a net margin of 3.51% compared to TSURUHA Holdings, Inc.'s net margin of --. TSURUHA Holdings, Inc.'s return on equity of 9.9% beat Stemcell Holdings, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TSUSFTSURUHA Holdings, Inc.30.28% $0.26 $2.6B STMMStemcell Holdings, Inc.-- -- -- -
What do Analysts Say About TSUSF or STMM?
TSURUHA Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Stemcell Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that TSURUHA Holdings, Inc. has higher upside potential than Stemcell Holdings, Inc., analysts believe TSURUHA Holdings, Inc. is more attractive than Stemcell Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TSUSFTSURUHA Holdings, Inc.0 0 0 STMMStemcell Holdings, Inc.0 0 0 -
Is TSUSF or STMM More Risky?
TSURUHA Holdings, Inc. has a beta of 0.413, which suggesting that the stock is 58.676% less volatile than S&P 500. In comparison Stemcell Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock TSUSF or STMM?
TSURUHA Holdings, Inc. has a quarterly dividend of $0.91 per share corresponding to a yield of 7.28%. Stemcell Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. TSURUHA Holdings, Inc. pays 59.57% of its earnings as a dividend. Stemcell Holdings, Inc. pays out -- of its earnings as a dividend. TSURUHA Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TSUSF or STMM?
TSURUHA Holdings, Inc. quarterly revenues are $1.9B, which are larger than Stemcell Holdings, Inc. quarterly revenues of --. TSURUHA Holdings, Inc.'s net income of $68.4M is higher than Stemcell Holdings, Inc.'s net income of --. Notably, TSURUHA Holdings, Inc.'s price-to-earnings ratio is 5.77x while Stemcell Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TSURUHA Holdings, Inc. is 0.34x versus 0.17x for Stemcell Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TSUSFTSURUHA Holdings, Inc.0.34x 5.77x $1.9B $68.4M STMMStemcell Holdings, Inc.0.17x -- -- --
-
Which has Higher Returns TSUSF or TAK?
Takeda Pharmaceutical Co., Ltd. has a net margin of 3.51% compared to TSURUHA Holdings, Inc.'s net margin of -1.05%. TSURUHA Holdings, Inc.'s return on equity of 9.9% beat Takeda Pharmaceutical Co., Ltd.'s return on equity of 0.55%.
Company Gross Margin Earnings Per Share Invested Capital TSUSFTSURUHA Holdings, Inc.30.28% $0.26 $2.6B TAKTakeda Pharmaceutical Co., Ltd.47.41% -$0.03 $79.7B -
What do Analysts Say About TSUSF or TAK?
TSURUHA Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Takeda Pharmaceutical Co., Ltd. has an analysts' consensus of $17.76 which suggests that it could grow by 25.04%. Given that Takeda Pharmaceutical Co., Ltd. has higher upside potential than TSURUHA Holdings, Inc., analysts believe Takeda Pharmaceutical Co., Ltd. is more attractive than TSURUHA Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TSUSFTSURUHA Holdings, Inc.0 0 0 TAKTakeda Pharmaceutical Co., Ltd.3 0 0 -
Is TSUSF or TAK More Risky?
TSURUHA Holdings, Inc. has a beta of 0.413, which suggesting that the stock is 58.676% less volatile than S&P 500. In comparison Takeda Pharmaceutical Co., Ltd. has a beta of 0.032, suggesting its less volatile than the S&P 500 by 96.811%.
-
Which is a Better Dividend Stock TSUSF or TAK?
TSURUHA Holdings, Inc. has a quarterly dividend of $0.91 per share corresponding to a yield of 7.28%. Takeda Pharmaceutical Co., Ltd. offers a yield of 4.66% to investors and pays a quarterly dividend of $0.32 per share. TSURUHA Holdings, Inc. pays 59.57% of its earnings as a dividend. Takeda Pharmaceutical Co., Ltd. pays out 242.25% of its earnings as a dividend. TSURUHA Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Takeda Pharmaceutical Co., Ltd.'s is not.
-
Which has Better Financial Ratios TSUSF or TAK?
TSURUHA Holdings, Inc. quarterly revenues are $1.9B, which are smaller than Takeda Pharmaceutical Co., Ltd. quarterly revenues of $7.5B. TSURUHA Holdings, Inc.'s net income of $68.4M is higher than Takeda Pharmaceutical Co., Ltd.'s net income of -$79.5M. Notably, TSURUHA Holdings, Inc.'s price-to-earnings ratio is 5.77x while Takeda Pharmaceutical Co., Ltd.'s PE ratio is 179.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for TSURUHA Holdings, Inc. is 0.34x versus 1.53x for Takeda Pharmaceutical Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TSUSFTSURUHA Holdings, Inc.0.34x 5.77x $1.9B $68.4M TAKTakeda Pharmaceutical Co., Ltd.1.53x 179.95x $7.5B -$79.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
